Josh N Vo - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Josh N Vo

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

Cell Reports. Medicine|October 1, 2024

Development of an orally bioavailable CDK12/13 degrader and induction of synthetic lethality with AKT pathway inhibitionYu Chang, Xiaoju Wang, Jianzhang Yang, et al.

Nature Cancer|November 5, 2021

Autophagy Inhibition by Targeting PIKfyve Potentiates Response to Immune Checkpoint Blockade in Prostate CancerYuanyuan Qiao, Jae Eun Choi, Jean C Tien, et al.

Nature|December 23, 2021

Targeting SWI/SNF ATPases in enhancer-addicted prostate cancerLanbo Xiao, Abhijit Parolia, Yuanyuan Qiao, et al.

Biorxiv : the Preprint Server for Biology|May 18, 2026

A complete human pancreatic cancer genomeJustin Wagner, Ayse G Keskus, Keisuke K Oshima, et al.

Pageof 2

Search research articles

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

Cell Reports. Medicine|October 1, 2024

Development of an orally bioavailable CDK12/13 degrader and induction of synthetic lethality with AKT pathway inhibitionYu Chang, Xiaoju Wang, Jianzhang Yang, et al.

Nature Cancer|November 5, 2021

Autophagy Inhibition by Targeting PIKfyve Potentiates Response to Immune Checkpoint Blockade in Prostate CancerYuanyuan Qiao, Jae Eun Choi, Jean C Tien, et al.

Nature|December 23, 2021

Targeting SWI/SNF ATPases in enhancer-addicted prostate cancerLanbo Xiao, Abhijit Parolia, Yuanyuan Qiao, et al.

Biorxiv : the Preprint Server for Biology|May 18, 2026

A complete human pancreatic cancer genomeJustin Wagner, Ayse G Keskus, Keisuke K Oshima, et al.

Pageof 2